Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats
- 28 February 2003
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 27 (1) , 185-195
- https://doi.org/10.1016/s0278-5846(02)00351-2
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2001
- Changes in memory processing with ageCurrent Opinion in Neurobiology, 2000
- 5-HT system and cognitionNeuroscience & Biobehavioral Reviews, 1999
- Central 5-HT4 receptorsTrends in Pharmacological Sciences, 1995
- CNS Nicotinic ReceptorsCNS Drugs, 1994
- Dissociation of Object and Spatial Processing Domains in Primate Prefrontal CortexScience, 1993
- Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor proteinNeuron, 1993
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIAThe Lancet, 1977
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976